# E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer

> **NCT00388726** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 762 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** E7389
- **DRUG:** Physician's Choice

## Key facts

- **NCT ID:** NCT00388726
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-05
- **Final completion:** 2013-06
- **Target enrollment:** 762 (ACTUAL)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388726, "E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00388726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*